EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Leader cells promote immunosuppression to drive ovarian cancer progression in vivo

Amy L Wilson, Laura R Moffitt, Brittany R Doran, Bashira Basri, Jennie Do, Thomas W Jobling, Magdalena Plebanski, Andrew N Stephens, Maree Bilandzic

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Amy L Wilson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, A…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Disease Progression. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ovarian Cancer Research Foundation, State Government of Victoria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsDisease ProgressionAnimalsFemaleMiceT-Lymphocytes, RegulatoryHumansImmune ToleranceMice, Inbred C57BLCell Line, TumorChemokine CCL22Mice, KnockoutImmunosuppression TherapyCarcinoma, Ovarian EpithelialMacrophagesNeoplasm MetastasisChemokine CCL5

Stichwörter der Autor:innen

CP: CancerT regulatory cellscancer metastasischemokinesimmunosuppressionkeratin-14leader cellsovarian cancer

Substanzen

Chemokine CCL22Chemokine CCL5

Autor:innen und Institutionen

  • Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia.
  • Hudson Institute of Medical Research, Clayton, VIC, Australia.
  • Monash Medical Centre, Department of Gynecology Oncology, Monash Health, 823-865 Centre Rd, Bentleigh East, VIC 3165, Australia.
  • School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
  • Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia. Electronic address: maree.bilandzic@hudson.org.au.

Förderung

  • Ovarian Cancer Research Foundation
  • State Government of Victoria

Zitieren

APA

Wilson, A. L., Moffitt, L. R., Doran, B. R., Basri, B., Do, J., Jobling, T. W., Plebanski, M., Stephens, A. N., & Bilandzic, M. (2024). Leader cells promote immunosuppression to drive ovarian cancer progression in vivo. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114979

Vancouver

Wilson AL, Moffitt LR, Doran BR, Basri B, Do J, Jobling TW, et al. Leader cells promote immunosuppression to drive ovarian cancer progression in vivo. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114979

BibTeX
@article{Wilson2024,
  author = {Wilson, Amy L and Moffitt, Laura R and Doran, Brittany R and Basri, Bashira and Do, Jennie and Jobling, Thomas W and Plebanski, Magdalena and Stephens, Andrew N and Bilandzic, Maree},
  title = {Leader cells promote immunosuppression to drive ovarian cancer progression in vivo},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114979}
}
Kostenlos starten →